Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Development of IP strategy

Reference number
Coordinator Celemiab International AB - CELEMI Celemiab International AB
Funding from Vinnova SEK 100 000
Project duration June 2021 - December 2021
Status Completed

Important results from the project

** Denna text är maskinöversatt ** The goal was to establish a clear IP strategy, this is in place including a routine for continuously working with IP issues.

Expected long term effects

** Denna text är maskinöversatt ** The documented IP strategy helps us to effectively invest our funds in a consistent way to build IP value in the company in both the short and long term. It has already helped us in a number of decisions.

Approach and implementation

** Denna text är maskinöversatt ** The project has had a clear phase division, part 1 Analysis: identification and ownership issues Internally. Part 2 Strategic analysis, part 3 Development of strategy and plan for implementation. All three parts have added great value, first a clear picture of the current situation and the IP in the company, part 2 a picture of opportunities in the market and the competitive situation and finally the development of a strategy with clearly identified decision bases for implementation.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 14 January 2022

Reference number 2021-02119